🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess if a zoledronic acid injection can a...
Status
Terminated
Location
University of Calgary
Start Date
2023-05-16
Trial ID
NCT05204836
Treatments Being Tested
This project employs a prospective, randomized, controlled, blinded, dual-c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-18
Trial ID
NCT07374211
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
A prospective, randomized, placebo controlled, double-blinded study at a si...
Status
Terminated
Location
SJHMC/Barrow Neurosurgical Associates
Start Date
2015-03-01
Trial ID
NCT02276911
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
Comparison of the safety and effectiveness of standard drug dosing versus a...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00250432
Treatments Being Tested
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
This is a prospective, open label, controlled, single center real-world obs...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2025-05-19
Trial ID
NCT07135778
This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Status
Terminated
Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Start Date
2022-12-07
Trial ID
NCT04915404
Treatments Being Tested
The overall goal of this exploratory proof-of-concept study is to determine...
Status
Completed
Location
Task Applied Science and Stellenbosch University
Start Date
2017-08-23
Trial ID
NCT03174184